Cancer Genomic Profiling Identified Dihydropyrimidine Dehydrogenase Deficiency in Bladder Cancer Promotes Vulnerability to Gemcitabine

Shigehiro Tsukahara(Kyushu University), Dongchon Kang(Kyushu University)
Research Square
February 15, 2022
10.21203/rs.3.rs-1322840/v1
Cited by 0

Related Papers

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine
|Scientific Reports|2022|4
膀胱癌におけるジヒドロピリミジン脱水素酵素の欠損がゲムシタビンに対する感受性を促進する
|Institutional Repositories DataBase (IRDB)|2022|0